ROL vs SNOA · P/E 41, rev $1.99B vs rev $19.5M
Rollins Inc (ROL) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the ROL and SNOA stock pages for the full models.
Not investment advice.